25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BIOQ (Bioqual) Stock Analysis
Buy, Hold or Sell?

Let's analyze Bioqual together

I guess you are interested in Bioqual Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Bioqual’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Bioqual’s Price Targets

I'm going to help you getting a better view of Bioqual Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Bioqual Inc

I send you an email if I find something interesting about Bioqual Inc.

1. Quick Overview

1.1. Quick analysis of Bioqual (30 sec.)










1.2. What can you expect buying and holding a share of Bioqual? (30 sec.)

How much money do you get?

How much money do you get?
$0.40
When do you have the money?
1 year
How often do you get paid?
67.5%

What is your share worth?

Current worth
$40.53
Expected worth in 1 year
$38.47
How sure are you?
85.0%

+ What do you gain per year?

Total Gains per Share
$-1.66
Return On Investment
-3.7%

For what price can you sell your share?

Current Price per Share
$44.25
Expected price per share
$44.25 - $45.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bioqual (5 min.)




Live pricePrice per Share (EOD)
$44.25
Intrinsic Value Per Share
$1.76 - $230.37
Total Value Per Share
$42.29 - $270.90

2.2. Growth of Bioqual (5 min.)




Is Bioqual growing?

Current yearPrevious yearGrowGrow %
How rich?$36.2m$38.2m-$1.2m-3.3%

How much money is Bioqual making?

Current yearPrevious yearGrowGrow %
Making money-$370.4k$227.3k-$597.7k-161.4%
Net Profit Margin-3.6%1.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Bioqual (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#80 / 129

Most Revenue
#87 / 129

Most Profit
#52 / 129
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bioqual?

Welcome investor! Bioqual's management wants to use your money to grow the business. In return you get a share of Bioqual.

First you should know what it really means to hold a share of Bioqual. And how you can make/lose money.

Speculation

The Price per Share of Bioqual is $44.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bioqual.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bioqual, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $40.53. Based on the TTM, the Book Value Change Per Share is $-0.51 per quarter. Based on the YOY, the Book Value Change Per Share is $0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bioqual.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps1.052.4%-0.41-0.9%0.250.6%0.210.5%0.691.6%0.821.9%
Usd Book Value Change Per Share1.052.4%-0.51-1.2%0.090.2%0.040.1%0.541.2%0.671.5%
Usd Dividend Per Share0.000.0%0.100.2%0.170.4%0.250.6%0.561.3%0.521.2%
Usd Total Gains Per Share1.052.4%-0.41-0.9%0.250.6%0.290.7%1.102.5%1.192.7%
Usd Price Per Share60.00-68.00-68.33-72.08-73.77-49.59-
Price to Earnings Ratio14.33-4.37-7.16-4.63-9.17-8.06-
Price-to-Total Gains Ratio57.33-17.46-28.64-16.94-25.22-29.02-
Price to Book Ratio1.48-1.64-1.60-1.70-1.97-1.51-
Price-to-Total Gains Ratio57.33-17.46-28.64-16.94-25.22-29.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share44.25
Number of shares22
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.100.56
Usd Book Value Change Per Share-0.510.54
Usd Total Gains Per Share-0.411.10
Gains per Quarter (22 shares)-9.1124.23
Gains per Year (22 shares)-36.4596.93
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
19-45-46504787
218-90-829995184
326-136-118149142281
435-181-154199189378
544-226-190248236475
653-271-226298284572
762-317-262348331669
870-362-298397378766
979-407-334447425863
1088-452-370497473960

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.03.00.040.0%7.05.00.058.3%16.05.00.076.2%35.05.00.087.5%66.08.00.089.2%
Book Value Change Per Share2.03.00.040.0%7.05.00.058.3%15.06.00.071.4%32.06.02.080.0%60.012.02.081.1%
Dividend per Share1.00.04.020.0%4.00.08.033.3%12.00.09.057.1%27.00.013.067.5%41.00.033.055.4%
Total Gains per Share2.03.00.040.0%7.05.00.058.3%15.06.00.071.4%34.06.00.085.0%63.011.00.085.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Bioqual Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.047-0.514+149%0.088+1096%0.043+2306%0.537+95%0.673+56%
Book Value Per Share--40.53141.371-2%42.738-5%42.317-4%38.622+5%30.598+32%
Current Ratio--5.0794.297+18%3.984+27%4.089+24%3.850+32%4.460+14%
Debt To Asset Ratio--0.3530.347+2%0.371-5%0.368-4%0.383-8%0.294+20%
Debt To Equity Ratio--0.5450.533+2%0.589-8%0.585-7%0.626-13%0.456+20%
Dividend Per Share---0.100-100%0.167-100%0.250-100%0.564-100%0.517-100%
Enterprise Value--45641453.00054069119.600-16%46558290.333-2%50584655.833-10%54484084.259-16%45473115.607+0%
Eps--1.047-0.414+140%0.254+312%0.210+398%0.694+51%0.819+28%
Ev To Ebitda Ratio--6.0523.911+55%12.957-53%-8.256+236%-2.182+136%0.895+576%
Ev To Sales Ratio--0.8131.070-24%0.734+11%0.891-9%0.946-14%0.907-10%
Free Cash Flow Per Share--0.2900.449-35%2.327-88%1.022-72%0.412-30%0.237+22%
Free Cash Flow To Equity Per Share--0.2900.349-17%2.160-87%0.772-62%-0.152+153%-0.196+168%
Gross Profit Margin--1.0001.0000%1.0000%0.952+5%0.792+26%0.820+22%
Intrinsic Value_10Y_max--230.369----------
Intrinsic Value_10Y_min--1.759----------
Intrinsic Value_1Y_max--6.846----------
Intrinsic Value_1Y_min--0.822----------
Intrinsic Value_3Y_max--32.946----------
Intrinsic Value_3Y_min--1.925----------
Intrinsic Value_5Y_max--73.966----------
Intrinsic Value_5Y_min--2.423----------
Market Cap39577908.000-36%53664960.00060820288.000-12%61118426.667-12%64472563.500-17%68702571.307-22%45783325.716+17%
Net Profit Margin--0.067-0.036+154%0.015+349%0.004+1410%0.041+64%0.065+2%
Operating Margin--0.092-0.055+160%0.017+428%0.000+101%0.051+81%0.0920%
Operating Ratio--0.9161.065-14%0.985-7%1.006-9%0.952-4%0.930-2%
Pb Ratio1.092-36%1.4801.644-10%1.601-8%1.703-13%1.966-25%1.508-2%
Pe Ratio10.571-36%14.3334.366+228%7.161+100%4.633+209%9.165+56%8.057+78%
Price Per Share44.250-36%60.00068.000-12%68.333-12%72.083-17%73.769-19%49.590+21%
Price To Free Cash Flow Ratio38.160-36%51.7429.642+437%-2.656+105%98.694-48%61.946-16%33.328+55%
Price To Total Gains Ratio42.283-36%57.33317.462+228%28.644+100%16.941+238%25.220+127%29.016+98%
Quick Ratio--4.9224.068+21%3.685+34%3.783+30%3.580+37%4.227+16%
Return On Assets--0.017-0.007+139%0.004+343%0.003+541%0.012+39%0.024-29%
Return On Equity--0.026-0.010+139%0.006+349%0.005+464%0.020+28%0.032-20%
Total Gains Per Share--1.047-0.414+140%0.254+312%0.293+257%1.101-5%1.190-12%
Usd Book Value--36251186.00037003275.800-2%38225757.333-5%37849451.083-4%35247655.619+3%27736872.825+31%
Usd Book Value Change Per Share--1.047-0.514+149%0.088+1096%0.043+2306%0.537+95%0.673+56%
Usd Book Value Per Share--40.53141.371-2%42.738-5%42.317-4%38.622+5%30.598+32%
Usd Dividend Per Share---0.100-100%0.167-100%0.250-100%0.564-100%0.517-100%
Usd Enterprise Value--45641453.00054069119.600-16%46558290.333-2%50584655.833-10%54484084.259-16%45473115.607+0%
Usd Eps--1.047-0.414+140%0.254+312%0.210+398%0.694+51%0.819+28%
Usd Free Cash Flow--259290.000401638.600-35%2081164.667-88%913866.833-72%410150.476-37%233781.350+11%
Usd Free Cash Flow Per Share--0.2900.449-35%2.327-88%1.022-72%0.412-30%0.237+22%
Usd Free Cash Flow To Equity Per Share--0.2900.349-17%2.160-87%0.772-62%-0.152+153%-0.196+168%
Usd Market Cap39577908.000-36%53664960.00060820288.000-12%61118426.667-12%64472563.500-17%68702571.307-22%45783325.716+17%
Usd Price Per Share44.250-36%60.00068.000-12%68.333-12%72.083-17%73.769-19%49.590+21%
Usd Profit--936030.000-370432.000+140%227332.333+312%187922.083+398%665216.190+41%755854.700+24%
Usd Revenue--14032982.00012868305.000+9%15838953.333-11%14733119.000-5%14636042.476-4%12028217.900+17%
Usd Total Gains Per Share--1.047-0.414+140%0.254+312%0.293+257%1.101-5%1.190-12%
 EOD+4 -4MRQTTM+19 -20YOY+20 -193Y+22 -185Y+25 -1510Y+27 -13

3.3 Fundamental Score

Let's check the fundamental score of Bioqual Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1510.571
Price to Book Ratio (EOD)Between0-11.092
Net Profit Margin (MRQ)Greater than00.067
Operating Margin (MRQ)Greater than00.092
Quick Ratio (MRQ)Greater than14.922
Current Ratio (MRQ)Greater than15.079
Debt to Asset Ratio (MRQ)Less than10.353
Debt to Equity Ratio (MRQ)Less than10.545
Return on Equity (MRQ)Greater than0.150.026
Return on Assets (MRQ)Greater than0.050.017
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Bioqual Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 5044.775
Ma 50Greater thanMa 10050.309
Ma 100Greater thanMa 20055.219
OpenGreater thanClose44.250
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Bioqual Inc

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

Fundamental data was last updated by Penke on 2025-06-05 10:03:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Bioqual earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • A Net Profit Margin of 6.7%Β means thatΒ $0.07 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bioqual Inc:

  • The MRQ is 6.7%. The company is making a profit. +1
  • The TTM is -3.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ6.7%TTM-3.6%+10.2%
TTM-3.6%YOY1.5%-5.1%
TTM-3.6%5Y4.1%-7.7%
5Y4.1%10Y6.5%-2.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7%-5.2%+11.9%
TTM-3.6%-7.6%+4.0%
YOY1.5%-2.9%+4.4%
3Y0.4%-14.6%+15.0%
5Y4.1%-4.9%+9.0%
10Y6.5%-1.0%+7.5%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Bioqual is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • 1.7% Return on Assets means thatΒ Bioqual generatedΒ $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bioqual Inc:

  • The MRQ is 1.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is -0.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.7%TTM-0.7%+2.3%
TTM-0.7%YOY0.4%-1.0%
TTM-0.7%5Y1.2%-1.9%
5Y1.2%10Y2.4%-1.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7%-1.1%+2.8%
TTM-0.7%-1.2%+0.5%
YOY0.4%-0.9%+1.3%
3Y0.3%-1.1%+1.4%
5Y1.2%0.1%+1.1%
10Y2.4%0.3%+2.1%
4.3.1.3. Return on Equity

Shows how efficient Bioqual is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • 2.6% Return on Equity means Bioqual generated $0.03Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bioqual Inc:

  • The MRQ is 2.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -1.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ2.6%TTM-1.0%+3.6%
TTM-1.0%YOY0.6%-1.6%
TTM-1.0%5Y2.0%-3.0%
5Y2.0%10Y3.2%-1.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6%-0.7%+3.3%
TTM-1.0%-0.8%-0.2%
YOY0.6%0.3%+0.3%
3Y0.5%-0.9%+1.4%
5Y2.0%0.3%+1.7%
10Y3.2%-1.0%+4.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Bioqual Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Bioqual is operatingΒ .

  • Measures how much profit Bioqual makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • An Operating Margin of 9.2%Β means the company generated $0.09 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bioqual Inc:

  • The MRQ is 9.2%. The company is operating less efficient.
  • The TTM is -5.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ9.2%TTM-5.5%+14.7%
TTM-5.5%YOY1.7%-7.3%
TTM-5.5%5Y5.1%-10.6%
5Y5.1%10Y9.2%-4.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ9.2%-14.3%+23.5%
TTM-5.5%-11.0%+5.5%
YOY1.7%-0.1%+1.8%
3Y0.0%0.6%-0.6%
5Y5.1%4.7%+0.4%
10Y9.2%4.9%+4.3%
4.3.2.2. Operating Ratio

Measures how efficient Bioqual is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • An Operation Ratio of 0.92 means that the operating costs are $0.92 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bioqual Inc:

  • The MRQ is 0.916. The company is less efficient in keeping operating costs low.
  • The TTM is 1.065. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.916TTM1.065-0.149
TTM1.065YOY0.985+0.080
TTM1.0655Y0.952+0.113
5Y0.95210Y0.930+0.022
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9161.360-0.444
TTM1.0651.299-0.234
YOY0.9851.275-0.290
3Y1.0061.274-0.268
5Y0.9521.277-0.325
10Y0.9301.192-0.262
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Bioqual Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bioqual is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • A Current Ratio of 5.08Β means the company has $5.08 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bioqual Inc:

  • The MRQ is 5.079. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.297. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.079TTM4.297+0.782
TTM4.297YOY3.984+0.312
TTM4.2975Y3.850+0.446
5Y3.85010Y4.460-0.609
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0792.192+2.887
TTM4.2972.146+2.151
YOY3.9842.367+1.617
3Y4.0892.449+1.640
5Y3.8502.552+1.298
10Y4.4603.154+1.306
4.4.3.2. Quick Ratio

Measures if Bioqual is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • A Quick Ratio of 4.92Β means the company can pay off $4.92 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bioqual Inc:

  • The MRQ is 4.922. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.068. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.922TTM4.068+0.854
TTM4.068YOY3.685+0.383
TTM4.0685Y3.580+0.488
5Y3.58010Y4.227-0.647
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9221.105+3.817
TTM4.0681.217+2.851
YOY3.6851.354+2.331
3Y3.7831.587+2.196
5Y3.5801.803+1.777
10Y4.2272.178+2.049
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Bioqual Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of BioqualΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Bioqual to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.35Β means that Bioqual assets areΒ financed with 35.3% credit (debt) and the remaining percentage (100% - 35.3%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Bioqual Inc:

  • The MRQ is 0.353. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.347. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.353TTM0.347+0.006
TTM0.347YOY0.371-0.024
TTM0.3475Y0.383-0.037
5Y0.38310Y0.294+0.089
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3530.405-0.052
TTM0.3470.437-0.090
YOY0.3710.398-0.027
3Y0.3680.400-0.032
5Y0.3830.417-0.034
10Y0.2940.443-0.149
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Bioqual is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 54.5% means that company has $0.54 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bioqual Inc:

  • The MRQ is 0.545. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.533. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.545TTM0.533+0.011
TTM0.533YOY0.589-0.056
TTM0.5335Y0.626-0.093
5Y0.62610Y0.456+0.171
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5450.592-0.047
TTM0.5330.584-0.051
YOY0.5890.598-0.009
3Y0.5850.718-0.133
5Y0.6260.692-0.066
10Y0.4560.650-0.194
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Bioqual generates.

  • Above 15 is considered overpriced butΒ always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • A PE ratio of 14.33 means the investor is paying $14.33Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bioqual Inc:

  • The EOD is 10.571. Based on the earnings, the company is underpriced. +1
  • The MRQ is 14.333. Based on the earnings, the company is underpriced. +1
  • The TTM is 4.366. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD10.571MRQ14.333-3.762
MRQ14.333TTM4.366+9.968
TTM4.366YOY7.161-2.795
TTM4.3665Y9.165-4.799
5Y9.16510Y8.057+1.108
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD10.571-0.545+11.116
MRQ14.333-0.852+15.185
TTM4.366-0.628+4.994
YOY7.161-0.132+7.293
3Y4.6331.934+2.699
5Y9.1655.834+3.331
10Y8.05710.198-2.141
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bioqual Inc:

  • The EOD is 38.160. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 51.742. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 9.642. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD38.160MRQ51.742-13.582
MRQ51.742TTM9.642+42.100
TTM9.642YOY-2.656+12.298
TTM9.6425Y61.946-52.304
5Y61.94610Y33.328+28.618
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD38.160-0.901+39.061
MRQ51.742-1.306+53.048
TTM9.642-0.639+10.281
YOY-2.656-0.791-1.865
3Y98.694-0.503+99.197
5Y61.946-0.763+62.709
10Y33.328-1.832+35.160
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Bioqual is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.48 means the investor is paying $1.48Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bioqual Inc:

  • The EOD is 1.092. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.480. Based on the equity, the company is underpriced. +1
  • The TTM is 1.644. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.092MRQ1.480-0.389
MRQ1.480TTM1.644-0.163
TTM1.644YOY1.601+0.043
TTM1.6445Y1.966-0.323
5Y1.96610Y1.508+0.458
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.0921.881-0.789
MRQ1.4801.977-0.497
TTM1.6442.050-0.406
YOY1.6012.386-0.785
3Y1.7032.486-0.783
5Y1.9663.421-1.455
10Y1.5084.314-2.806
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-02-292024-05-312024-08-312024-11-302025-02-28
Other Operating Expenses  15,102-1,31213,790-88812,90231313,215-26,075-12,860



6.2. Latest Balance Sheet

Balance Sheet of 2025-02-28. All numbers in thousands.

Summary
Total Assets55,998
Total Liabilities19,746
Total Stockholder Equity36,251
 As reported
Total Liabilities 19,746
Total Stockholder Equity+ 36,251
Total Assets = 55,998

Assets

Total Assets55,998
Total Current Assets29,167
Long-term Assets26,831
Total Current Assets
Cash And Cash Equivalents 11,723
Net Receivables 16,539
Other Current Assets 905
Total Current Assets  (as reported)29,167
Total Current Assets  (calculated)29,167
+/-0
Long-term Assets
Property Plant Equipment 25,761
Goodwill 1,028
Long-term Assets Other 19
Long-term Assets  (as reported)26,831
Long-term Assets  (calculated)26,808
+/- 23

Liabilities & Shareholders' Equity

Total Current Liabilities5,742
Long-term Liabilities14,004
Total Stockholder Equity36,251
Total Current Liabilities
Short-term Debt 3,498
Accounts payable 741
Other Current Liabilities 1,293
Total Current Liabilities  (as reported)5,742
Total Current Liabilities  (calculated)5,532
+/- 211
Long-term Liabilities
Long-term Liabilities  (as reported)14,004
Long-term Liabilities  (calculated)0
+/- 14,004
Total Stockholder Equity
Common Stock16
Retained Earnings 29,911
Other Stockholders Equity 6,324
Total Stockholder Equity (as reported)36,251
Total Stockholder Equity (calculated)36,251
+/-0
Other
Cash and Short Term Investments 11,723
Common Stock Shares Outstanding 894
Current Deferred Revenue211
Liabilities and Stockholders Equity 55,998
Net Debt 5,780
Net Working Capital 23,424
Short Long Term Debt Total 17,503



6.3. Balance Sheets Structured

All numbers in thousands.

 Trend2025-02-282024-11-302024-08-312024-05-312024-02-292023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-302018-08-312018-05-312018-02-282017-11-302017-08-312017-05-312017-02-282016-11-302016-08-312016-05-312016-02-292015-11-302015-08-312015-05-312015-02-282014-11-302014-08-312014-05-312014-02-282013-11-302013-08-312013-05-312013-02-282012-11-302011-08-312011-05-312011-02-282010-11-302010-08-312010-05-312010-02-282009-11-302007-05-312007-02-282006-11-302006-08-312006-05-312006-02-282005-11-302005-08-312002-02-282001-11-302001-08-312001-05-312001-02-282000-11-302000-08-312000-05-312000-02-291999-11-30
> Total Assets 
4,948
4,894
5,326
4,838
4,748
5,010
4,874
5,036
5,013
5,050
0
0
0
8,688
9,034
8,786
9,411
10,152
0
0
12,233
0
11,840
11,861
13,297
13,998
12,259
11,792
11,790
11,727
11,656
14,157
15,477
15,656
15,904
16,426
17,363
16,912
17,229
18,381
19,427
19,832
0
0
22,760
23,024
23,119
24,124
26,305
26,667
26,330
27,580
28,310
45,664
47,819
47,500
49,548
50,704
51,312
50,308
53,420
53,615
61,550
61,996
63,342
65,284
64,034
61,738
61,317
61,491
59,427
58,865
56,588
53,836
58,148
55,998
55,99858,14853,83656,58858,86559,42761,49161,31761,73864,03465,28463,34261,99661,55053,61553,42050,30851,31250,70449,54847,50047,81945,66428,31027,58026,33026,66726,30524,12423,11923,02422,7600019,83219,42718,38117,22916,91217,36316,42615,90415,65615,47714,15711,65611,72711,79011,79212,25913,99813,29711,86111,840012,2330010,1529,4118,7869,0348,6880005,0505,0135,0364,8745,0104,7484,8385,3264,8944,948
   > Total Current Assets 
2,130
2,040
2,480
2,106
2,130
2,236
2,256
2,481
2,529
2,651
0
0
0
4,947
5,067
4,637
5,348
6,153
0
0
8,545
0
8,501
8,651
9,979
10,867
9,836
9,473
9,498
9,568
9,621
8,169
9,688
10,049
10,377
11,080
12,133
11,844
12,130
13,395
14,596
14,954
6,666
0
17,901
17,640
17,433
18,064
20,253
20,485
19,919
20,826
21,271
22,138
24,694
24,740
26,255
26,672
27,522
26,391
29,322
29,082
28,746
29,666
31,728
31,034
30,385
29,603
29,940
31,577
30,921
31,771
30,874
29,511
30,079
29,167
29,16730,07929,51130,87431,77130,92131,57729,94029,60330,38531,03431,72829,66628,74629,08229,32226,39127,52226,67226,25524,74024,69422,13821,27120,82619,91920,48520,25318,06417,43317,64017,90106,66614,95414,59613,39512,13011,84412,13311,08010,37710,0499,6888,1699,6219,5689,4989,4739,83610,8679,9798,6518,50108,545006,1535,3484,6375,0674,9470002,6512,5292,4812,2562,2362,1302,1062,4802,0402,130
       Cash And Cash Equivalents 
70
71
72
73
74
75
76
77
77
78
0
0
0
2,251
281
446
752
2,794
0
0
3,153
0
2,004
1,410
2,719
3,760
4,388
4,082
4,844
4,493
5,305
2,914
1,978
2,730
1,924
2,457
3,709
3,066
3,714
5,459
5,178
6,666
-6,666
0
9,288
8,129
7,967
8,451
10,161
10,347
8,378
8,426
9,208
8,340
6,135
10,038
10,256
5,869
7,489
5,028
7,720
7,983
5,240
2,389
2,184
2,199
1,933
4,364
7,279
6,436
10,162
11,849
15,594
14,034
11,464
11,723
11,72311,46414,03415,59411,84910,1626,4367,2794,3641,9332,1992,1842,3895,2407,9837,7205,0287,4895,86910,25610,0386,1358,3409,2088,4268,37810,34710,1618,4517,9678,1299,2880-6,6666,6665,1785,4593,7143,0663,7092,4571,9242,7301,9782,9145,3054,4934,8444,0824,3883,7602,7191,4102,00403,153002,7947524462812,25100078777776757473727170
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,331
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000013,331000000000000000000000000000000000000000000
       Net Receivables 
1,564
1,545
1,970
1,577
1,654
1,816
1,739
1,935
2,060
2,226
0
0
0
2,514
4,479
3,903
4,307
2,894
0
0
5,218
0
6,155
7,015
7,112
6,730
4,781
4,606
4,064
4,383
4,044
4,773
7,436
6,927
8,207
8,324
7,869
8,119
8,089
7,835
9,323
7,558
0
0
8,276
9,061
8,777
9,244
9,265
9,127
10,170
11,442
11,429
12,601
17,656
14,015
14,449
19,414
17,852
19,104
20,108
19,670
21,006
24,830
26,764
26,427
24,854
21,517
20,642
22,183
18,791
18,456
14,003
13,649
15,792
16,539
16,53915,79213,64914,00318,45618,79122,18320,64221,51724,85426,42726,76424,83021,00619,67020,10819,10417,85219,41414,44914,01517,65612,60111,42911,44210,1709,1279,2659,2448,7779,0618,276007,5589,3237,8358,0898,1197,8698,3248,2076,9277,4364,7734,0444,3834,0644,6064,7816,7307,1127,0156,15505,218002,8944,3073,9034,4792,5140002,2262,0601,9351,7391,8161,6541,5771,9701,5451,564
       Inventory 
298
257
226
251
243
222
181
160
158
134
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000000000000134158160181222243251226257298
       Other Current Assets 
197
167
212
204
158
122
260
309
233
213
0
0
0
181
307
287
289
464
0
0
174
0
343
225
148
377
667
786
591
691
272
482
273
392
247
299
556
660
327
101
96
398
135
0
371
450
453
369
400
843
1,371
802
634
1,196
678
688
1,549
1,389
1,555
1,827
1,494
1,428
2,500
2,447
2,780
2,408
3,598
3,722
1,343
2,958
1,969
1,466
1,277
1,828
2,824
905
9052,8241,8281,2771,4661,9692,9581,3433,7223,5982,4082,7802,4472,5001,4281,4941,8271,5551,3891,5496886781,1966348021,371843400369453450371013539896101327660556299247392273482272691591786667377148225343017400464289287307181000213233309260122158204212167197
   > Long-term Assets 
2,818
2,853
2,846
2,732
2,618
2,773
2,618
2,555
2,484
2,400
0
0
0
3,741
3,967
4,149
4,063
4,000
0
0
3,689
0
3,339
3,210
3,318
3,132
1,498
2,319
2,292
2,159
2,035
5,988
5,789
5,607
5,526
5,346
5,231
5,068
5,100
4,986
4,831
4,878
-6,666
0
4,859
5,384
5,686
6,061
6,051
6,182
6,411
6,755
7,039
23,527
23,125
22,760
23,293
24,032
23,790
23,917
24,098
24,533
32,804
32,330
31,614
34,250
33,649
32,136
31,377
29,915
28,506
27,095
25,714
24,325
28,069
26,831
26,83128,06924,32525,71427,09528,50629,91531,37732,13633,64934,25031,61432,33032,80424,53324,09823,91723,79024,03223,29322,76023,12523,5277,0396,7556,4116,1826,0516,0615,6865,3844,8590-6,6664,8784,8314,9865,1005,0685,2315,3465,5265,6075,7895,9882,0352,1592,2922,3191,4983,1323,3183,2103,33903,689004,0004,0634,1493,9673,7410002,4002,4842,5552,6182,7732,6182,7322,8462,8532,818
       Property Plant Equipment 
1,504
1,617
1,607
1,597
1,507
1,413
1,413
1,466
1,516
1,527
0
0
0
3,136
3,362
3,544
3,458
3,344
0
0
2,895
0
2,545
2,416
2,482
2,295
1,498
1,394
1,268
1,135
1,011
3,622
3,421
3,276
3,244
3,100
2,986
2,860
2,894
2,783
2,821
2,991
0
0
2,948
3,476
3,780
4,157
4,288
4,421
4,653
4,999
5,294
21,784
21,385
21,022
21,496
22,236
21,997
22,125
22,958
23,392
31,645
31,171
30,586
33,203
32,602
31,089
30,349
28,868
27,459
26,048
24,662
23,255
26,999
25,761
25,76126,99923,25524,66226,04827,45928,86830,34931,08932,60233,20330,58631,17131,64523,39222,95822,12521,99722,23621,49621,02221,38521,7845,2944,9994,6534,4214,2884,1573,7803,4762,948002,9912,8212,7832,8942,8602,9863,1003,2443,2763,4213,6221,0111,1351,2681,3941,4982,2952,4822,4162,54502,895003,3443,4583,5443,3623,1360001,5271,5161,4661,4131,4131,5071,5971,6071,6171,504
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
0
0
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,028001,0281,0281,0281,0281,0281,0281,0281,0281,0281,02800000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
664
548
427
401
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000000000000401427548664000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,342
237
201
152
116
91
55
52
50
47
44
0
0
37
34
32
29
26
24
21
19
16
14
11
9
6
3
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000013691114161921242629323437004447505255911161522012371,3420000000000000000000000000000000
       Long-term Assets Other 
714
636
741
638
613
863
1,006
890
769
763
0
0
0
605
605
605
605
656
0
0
794
0
794
794
836
836
-1,498
925
1,024
1,024
1,024
1,024
1,102
1,102
1,102
1,102
1,125
1,125
1,125
1,125
934
815
-6,666
0
846
846
846
846
708
708
708
708
701
701
701
701
763
763
763
763
112
112
130
130
-31,614
19
19
19
-31,377
19
19
19
0
19
42
19
1942190191919-31,377191919-31,6141301301121127637637637637017017017017087087087088468468468460-6,6668159341,1251,1251,1251,1251,1021,1021,1021,1021,0241,0241,0241,024925-1,4988368367947940794006566056056056050007637698901,006863613638741636714
> Total Liabilities 
1,452
1,384
1,758
1,249
1,086
1,300
1,045
1,143
1,045
995
0
0
0
2,041
2,103
1,619
1,890
2,510
0
0
2,070
0
1,725
1,711
2,924
3,354
1,646
1,483
1,448
1,235
912
3,398
4,415
4,156
4,030
4,251
4,574
3,895
3,522
4,439
4,073
3,479
0
0
3,845
3,323
3,226
3,427
3,464
2,956
2,548
3,304
2,777
19,773
21,658
20,615
21,366
20,752
20,881
18,901
19,890
18,708
26,621
26,211
25,670
26,228
24,578
23,422
23,703
22,978
20,876
20,040
18,938
16,861
22,833
19,746
19,74622,83316,86118,93820,04020,87622,97823,70323,42224,57826,22825,67026,21126,62118,70819,89018,90120,88120,75221,36620,61521,65819,7732,7773,3042,5482,9563,4643,4273,2263,3233,845003,4794,0734,4393,5223,8954,5744,2514,0304,1564,4153,3989121,2351,4481,4831,6463,3542,9241,7111,72502,070002,5101,8901,6192,1032,0410009951,0451,1431,0451,3001,0861,2491,7581,3841,452
   > Total Current Liabilities 
1,433
1,379
1,568
1,086
946
1,204
962
1,089
1,023
985
0
0
0
1,573
1,661
1,194
1,465
2,181
0
0
1,491
0
1,192
1,197
2,477
2,898
1,646
1,483
1,448
1,235
912
1,476
2,524
2,285
2,182
2,684
3,091
2,468
2,179
3,084
3,072
2,567
0
0
3,100
2,601
2,531
2,748
3,464
2,956
2,548
3,304
2,777
5,083
7,290
7,047
7,682
6,635
7,585
6,446
8,517
8,056
9,502
9,754
9,765
8,280
7,026
6,871
8,297
7,626
7,356
7,531
7,688
6,655
8,054
5,742
5,7428,0546,6557,6887,5317,3567,6268,2976,8717,0268,2809,7659,7549,5028,0568,5176,4467,5856,6357,6827,0477,2905,0832,7773,3042,5482,9563,4642,7482,5312,6013,100002,5673,0723,0842,1792,4683,0912,6842,1822,2852,5241,4769121,2351,4481,4831,6462,8982,4771,1971,19201,491002,1811,4651,1941,6611,5730009851,0231,0899621,2049461,0861,5681,3791,433
       Short-term Debt 
898
891
811
475
387
645
302
379
479
364
0
0
0
0
316
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
271
276
276
276
276
289
289
289
289
303
303
0
0
317
317
317
301
250
168
86
0
0
0
0
0
0
0
0
0
3,303
3,217
3,256
3,170
3,071
3,539
3,071
3,196
3,442
2,598
3,476
3,532
3,587
3,639
3,381
3,498
3,4983,3813,6393,5873,5323,4762,5983,4423,1963,0713,5393,0713,1703,2563,2173,303000000000861682503013173173170030330328928928928927627627627627100000000000000003160000364479379302645387475811891898
       Short Long Term Debt 
0
0
0
0
0
0
302
379
479
364
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
567
489
317
301
250
168
86
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000861682503013174895670000000000000000000000000000000000364479379302000000
       Accounts payable 
157
193
201
208
117
209
168
326
210
197
0
0
0
569
439
436
392
409
0
0
401
0
340
482
599
581
402
556
313
518
310
391
618
303
611
489
807
592
647
1,336
1,222
1,293
0
0
1,241
891
1,305
1,177
1,804
1,556
1,017
1,900
1,312
909
1,265
1,764
2,476
1,667
2,233
864
2,108
1,758
3,123
2,923
3,289
1,543
1,515
1,119
1,594
3,077
1,499
1,295
1,380
1,429
1,433
741
7411,4331,4291,3801,2951,4993,0771,5941,1191,5151,5433,2892,9233,1231,7582,1088642,2331,6672,4761,7641,2659091,3121,9001,0171,5561,8041,1771,3058911,241001,2931,2221,336647592807489611303618391310518313556402581599482340040100409392436439569000197210326168209117208201193157
       Other Current Liabilities 
377
295
555
403
442
350
492
384
334
424
0
0
0
1,004
697
630
858
1,627
0
0
931
0
626
635
912
490
1,244
927
1,134
717
602
815
1,630
1,706
1,295
1,920
1,995
1,587
1,244
1,459
1,547
971
0
0
1,541
1,393
909
1,270
1,410
1,231
1,446
1,404
1,465
4,174
6,025
5,283
5,206
4,968
5,351
5,582
2,149
1,162
1,579
1,749
2,240
1,331
1,764
2,029
2,304
1,242
1,933
1,920
2,275
4,788
3,241
1,293
1,2933,2414,7882,2751,9201,9331,2422,3042,0291,7641,3312,2401,7491,5791,1622,1495,5825,3514,9685,2065,2836,0254,1741,4651,4041,4461,2311,4101,2709091,3931,541009711,5471,4591,2441,5871,9951,9201,2951,7061,6308156027171,1349271,2444909126356260931001,6278586306971,004000424334384492350442403555295377
   > Long-term Liabilities 
19
5
190
163
140
96
83
53
22
10
0
0
0
467
442
426
425
330
0
0
579
0
533
514
447
456
0
0
0
0
0
1,921
1,891
1,871
1,848
1,567
1,483
1,427
1,342
1,354
1,001
912
0
0
745
722
695
680
0
0
0
0
0
14,690
14,368
13,569
13,684
14,117
13,296
12,455
11,373
10,652
17,119
16,456
15,905
17,948
17,552
16,551
15,406
15,352
13,521
12,509
11,250
10,207
14,780
14,004
14,00414,78010,20711,25012,50913,52115,35215,40616,55117,55217,94815,90516,45617,11910,65211,37312,45513,29614,11713,68413,56914,36814,69000000680695722745009121,0011,3541,3421,4271,4831,5671,8481,8711,8911,921000004564475145330579003304254264424670001022538396140163190519
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
531
549
602
649
791
823
853
878
969
208
208
208
413
413
413
413
58
58
58
58
251
251
251
251
240
0
0
0
0
0
0
0
00000002402512512512515858585841341341341320820820896987885382379164960254953100000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
531
549
602
649
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000064960254953100000000000000000000000000000000000000000000
> Total Stockholder Equity
3,496
3,510
3,568
3,589
3,662
3,709
3,829
3,893
3,968
4,055
0
0
0
6,648
6,931
7,166
7,521
7,642
0
0
10,163
0
10,115
10,150
10,373
10,644
10,444
10,152
10,194
10,365
10,571
10,760
11,062
11,501
11,874
12,175
12,789
13,017
13,708
13,943
15,354
16,353
16,353
0
18,915
19,702
19,893
20,697
22,050
22,888
22,929
23,398
24,564
25,892
26,161
26,885
28,182
29,952
30,431
31,407
33,530
34,907
34,928
35,785
37,672
39,056
39,455
38,316
37,614
38,513
38,551
38,826
37,650
36,975
35,315
36,251
36,25135,31536,97537,65038,82638,55138,51337,61438,31639,45539,05637,67235,78534,92834,90733,53031,40730,43129,95228,18226,88526,16125,89224,56423,39822,92922,88822,05020,69719,89319,70218,915016,35316,35315,35413,94313,70813,01712,78912,17511,87411,50111,06210,76010,57110,36510,19410,15210,44410,64410,37310,15010,115010,163007,6427,5217,1666,9316,6480004,0553,9683,8933,8293,7093,6623,5893,5683,5103,496
   Common Stock
16
16
16
16
16
16
16
16
16
16
0
0
0
16
16
16
16
16
0
0
16
0
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
0
0
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
161616161616161616161616161616161616161616161616161616161616161600161616161616161616161616161616161616161601600161616161600016161616161616161616
   Retained Earnings 
-3,292
-3,282
-3,230
-3,209
-3,137
-3,090
-2,971
-2,911
-2,837
-2,749
0
0
0
282
564
800
1,151
1,260
0
0
3,800
0
3,752
3,834
4,058
4,329
4,136
3,856
3,892
4,064
4,270
4,459
4,760
5,200
5,573
5,874
6,488
6,716
7,407
7,642
9,054
10,053
0
0
12,615
13,402
13,593
14,392
15,741
16,576
16,614
17,079
18,242
19,567
19,833
20,553
21,847
23,614
24,091
25,067
27,190
28,567
28,589
29,445
31,333
32,716
33,116
31,976
31,274
32,173
32,211
32,486
31,310
30,635
28,975
29,911
29,91128,97530,63531,31032,48632,21132,17331,27431,97633,11632,71631,33329,44528,58928,56727,19025,06724,09123,61421,84720,55319,83319,56718,24217,07916,61416,57615,74114,39213,59313,40212,6150010,0539,0547,6427,4076,7166,4885,8745,5735,2004,7604,4594,2704,0643,8923,8564,1364,3294,0583,8343,75203,800001,2601,151800564282000-2,749-2,837-2,911-2,971-3,090-3,137-3,209-3,230-3,282-3,292
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000-691-690-690-692-692-692-693-693-6990
   Other Stockholders Equity 
6,772
6,776
6,782
6,782
6,783
6,783
6,785
6,788
6,788
6,788
0
0
0
6,350
6,351
6,351
6,354
6,366
0
0
6,347
0
6,347
6,299
6,299
6,299
6,291
6,280
6,285
6,285
6,285
6,285
6,285
6,285
6,285
6,285
6,285
6,285
6,285
6,285
6,284
6,284
0
0
6,284
6,284
6,284
6,289
6,293
6,296
6,299
6,302
6,306
6,309
6,312
6,316
6,319
6,322
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3226,3196,3166,3126,3096,3066,3026,2996,2966,2936,2896,2846,2846,284006,2846,2846,2856,2856,2856,2856,2856,2856,2856,2856,2856,2856,2856,2856,2806,2916,2996,2996,2996,34706,347006,3666,3546,3516,3516,3500006,7886,7886,7886,7856,7836,7836,7826,7826,7766,772



6.4. Balance Sheets

All numbers in thousands.




6.5. Cash Flows

All numbers in thousands.




6.6. Income Statements

All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-05-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue58,591
Cost of Revenue-51,162
Gross Profit7,4297,429
 
Operating Income (+$)
Gross Profit7,429
Operating Expense-7,449
Operating Income-20-20
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense7,4490
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-20
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)476-516
EBIT - interestExpense = 476
476
483
Interest Expense0
Earnings Before Interest and Taxes (EBIT)476476
Earnings Before Interest and Taxes (EBITDA)3,032
 
After tax Income (+$)
Income Before Tax476
Tax Provision-0
Net Income From Continuing Ops0476
Net Income483
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses58,115
Total Other Income/Expenses Net4960
 

Technical Analysis of Bioqual
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bioqual. The general trend of Bioqual is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bioqual's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Bioqual Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bioqual Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 45.00 < 45.00 < 45.00.

The bearish price targets are: 44.25.

Know someone who trades $BIOQ? Share this with them.πŸ‘‡

Bioqual Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bioqual Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bioqual Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bioqual Inc. The current macd is -1.75700574.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bioqual price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bioqual. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bioqual price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bioqual Inc Daily Moving Average Convergence/Divergence (MACD) ChartBioqual Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bioqual Inc. The current adx is 97.99.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bioqual shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Bioqual Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bioqual Inc. The current sar is 44.59.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bioqual Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bioqual Inc. The current rsi is 0.0000. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Bioqual Inc Daily Relative Strength Index (RSI) ChartBioqual Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bioqual Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bioqual price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Bioqual Inc Daily Stochastic Oscillator ChartBioqual Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bioqual Inc. The current cci is -117.21611722.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Bioqual Inc Daily Commodity Channel Index (CCI) ChartBioqual Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bioqual Inc. The current cmo is -100.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bioqual Inc Daily Chande Momentum Oscillator (CMO) ChartBioqual Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bioqual Inc. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Bioqual Inc Daily Williams %R ChartBioqual Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Bioqual Inc.

Bioqual Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bioqual Inc. The current atr is 0.1834387.

Bioqual Inc Daily Average True Range (ATR) ChartBioqual Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bioqual Inc. The current obv is -13,694.

Bioqual Inc Daily On-Balance Volume (OBV) ChartBioqual Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bioqual Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Bioqual Inc Daily Money Flow Index (MFI) ChartBioqual Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bioqual Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Bioqual Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bioqual Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 5044.775
Ma 50Greater thanMa 10050.309
Ma 100Greater thanMa 20055.219
OpenGreater thanClose44.250
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Bioqual with someone you think should read this too:
  • Are you bullish or bearish on Bioqual? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bioqual? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bioqual Inc

I send you an email if I find something interesting about Bioqual Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Bioqual Inc.

Receive notifications about Bioqual Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.